By tapping into the data analytics and expertise used to choreograph pitstops in Formula One, the French drugmaker is hoping to “maximize performance and operational excellence,” according to CEO Paul Hudson.
Sanofi is linking up with Formula One giant McLaren to optimize its manufacturing operations and improve efficiencies across the French major's supply chain.
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
The Swiss major follows Lilly and J&J in committing to a significant spend on US manufacturing.
China’s imposed large retaliatory tariffs on US pharmaceuticals on 10 April, but some domestic firms with in-licensed, US-origin assets were already moving to localized manufacturing.
The rollout of Trump’s tariff plan has been a policy whiplash, but despite a 90-day pause on tariffs, it appears the US president is still holding a grudge with industry over drug pricing.
European pharma leaders want to see a deal so that no tariffs are imposed on medicines – but they also want the European Union to urgently rethink its sector policies that they believe will lead to massive investment loss.
A letter to US Senate HELP Committee Chair Bill Cassiday sounds an alarm about irreparable damage to the FDA, signed by more than 200 biotech executives and investors.
Adstiladrin sales hit €70m in first full year on the market
Evaluate data show that biopharma companies raising cash in the smallest and largest categories of venture capital financings struggled to meet bars set in prior quarters.
